Thursday, June 11, 2015
BioAtla Gets $30M
San Diego-based biotherapeutics developer BioAtla announced today that it has raised $30M in an equity investment, from an un-named Chinese investor group. BioAtla, which is led by Jay M. Short, said the funds will go towards developing its antibody drug pipeline, as well as collaboration with biopharmaceutical companies and institutions in China. Short was previously President and CEO of Diversa Corporation.